Literature DB >> 1920633

Assembly of nucleocapsidlike structures in animal cells infected with a vaccinia virus recombinant encoding the measles virus nucleoprotein.

D Spehner1, A Kirn, R Drillien.   

Abstract

A vaccinia virus recombinant containing the measles virus nucleoprotein gene was shown to induce the synthesis of a 60 kDa phosphorylated nucleoprotein similar to authentic measles virus nucleoprotein. Mammalian or avian cells infected with the recombinant virus displayed tubular structures reminiscent of viral nucleocapsids both in the cytoplasm and in the nucleus. Such structures could be labelled in situ by using an immunogold detection method specific for measles virus proteins. Electron microscopic examination of tubular structures purified from cells infected with the vaccinia virus recombinant indicated that they displayed most of the features of measles virus nucleocapsids, although their length was on the average shorter. These results demonstrate the spontaneous assembly of measles virus nucleocapsids in the absence of viral leader RNA and provide a means for a detailed molecular analysis of the requirements for nucleocapsid assembly. Furthermore, these findings raise the possibility of achieving complete assembly of measles virus particles, devoid of infectious RNA, by using a vaccinia virus vector.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1920633      PMCID: PMC250336     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  11 in total

1.  Structural phosphoproteins associated with purified measles virions and cytoplasmic nucleocapsids.

Authors:  S J Robbins; R H Bussell
Journal:  Intervirology       Date:  1979       Impact factor: 1.763

2.  Cloning and sequencing of the nucleoprotein gene of measles virus (Hallé strain).

Authors:  R Buckland; C Gerald; D Barker; F Wild
Journal:  Nucleic Acids Res       Date:  1988-12-23       Impact factor: 16.971

3.  Development of measles virus in vitro.

Authors:  T Nakai; F L Shand; A F Howatson
Journal:  Virology       Date:  1969-05       Impact factor: 3.616

4.  Immunolabelling of bacteriophage lambda receptor protein (LamB) on thin sections of E. coli embedded in Lowicryl.

Authors:  R L Whitehouse; J C Benichou; E Couture-Tosi; S Schenkman; A Ryter
Journal:  Biol Cell       Date:  1984       Impact factor: 4.458

5.  N protein of vesicular stomatitis virus selectively encapsidates leader RNA in vitro.

Authors:  B M Blumberg; C Giorgi; D Kolakofsky
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

6.  Isolation and partial characterization of two forms of cytoplasmic nucleocapsids from measles virus-infected cells.

Authors:  S J Robbins; R H Bussell; F Rapp
Journal:  J Gen Virol       Date:  1980-04       Impact factor: 3.891

7.  Measles virus synthesizes both leaderless and leader-containing polyadenylated RNAs in vivo.

Authors:  S J Castaneda; T C Wong
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

8.  Contrasting of Lowicryl K4M thin sections.

Authors:  J Roth; D J Taatjes; K T Tokuyasu
Journal:  Histochemistry       Date:  1990

9.  Measles virus nucleocapsid protein protects rats from encephalitis.

Authors:  B Bankamp; U G Brinckmann; A Reich; S Niewiesk; V ter Meulen; U G Liebert
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

10.  Infectious measles virus from cloned cDNA.

Authors:  I Ballart; D Eschle; R Cattaneo; A Schmid; M Metzler; J Chan; S Pifko-Hirst; S A Udem; M A Billeter
Journal:  EMBO J       Date:  1990-02       Impact factor: 11.598

View more
  39 in total

1.  Ultrastructural organization of recombinant Marburg virus nucleoprotein: comparison with Marburg virus inclusions.

Authors:  L Kolesnikova; E Mühlberger; E Ryabchikova; S Becker
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Identification and characterization of a regulatory domain on the carboxyl terminus of the measles virus nucleocapsid protein.

Authors:  Xinsheng Zhang; Candace Glendening; Hawley Linke; Christopher L Parks; Charles Brooks; Stephen A Udem; Michael Oglesbee
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

3.  Intranuclear inclusions in paramyxovirus-induced encephalitis: evidence for altered nuclear body differentiation.

Authors:  M Oglesbee
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

4.  Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber.

Authors:  V Legrand; D Spehner; Y Schlesinger; N Settelen; A Pavirani; M Mehtali
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

5.  Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein.

Authors:  E C Coronel; T Takimoto; K G Murti; N Varich; A Portner
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Requirements for budding of paramyxovirus simian virus 5 virus-like particles.

Authors:  Anthony P Schmitt; George P Leser; David L Waning; Robert A Lamb
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Conformational maturation of measles virus nucleocapsid protein.

Authors:  A F Gombart; A Hirano; T C Wong
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  Orchid fleck virus structural proteins N and P form intranuclear viroplasm-like structures in the absence of viral infection.

Authors:  Hideki Kondo; Sotaro Chiba; Ida Bagus Andika; Kazuyuki Maruyama; Tetsuo Tamada; Nobuhiro Suzuki
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

9.  p38 and OGT sequestration into viral inclusion bodies in cells infected with human respiratory syncytial virus suppresses MK2 activities and stress granule assembly.

Authors:  Jens Fricke; Lily Y Koo; Charles R Brown; Peter L Collins
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

10.  Characterization of the Ebola virus nucleoprotein-RNA complex.

Authors:  Takeshi Noda; Kyoji Hagiwara; Hiroshi Sagara; Yoshihiro Kawaoka
Journal:  J Gen Virol       Date:  2010-02-17       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.